CETA: An Opportunity to Fix Canada’s Broken Pharmaceutical Patent Linkage System
This is an excerpt from a paper by Adam Falconi, the recipient of the 2015 Barry D. Tomo Memorial Prize for best research paper on
This is an excerpt from a paper by Adam Falconi, the recipient of the 2015 Barry D. Tomo Memorial Prize for best research paper on
This past fall I had the privilege of participating in Osgoode Hall Law School’s Intellectual Property and Technology Law Intensive Program. The placement allowed me
On September 23, Canada’s Competition Bureau (“the Bureau”) announced landmark guidelines regarding the consideration of pharmaceutical patent litigation settlements under Canada’s competition law framework. The
The course Legal Values: Commercializing Intellectual Property is being offered for the first time at Osgoode Hall Law School this winter term. The IPilogue sat down with Adjunct
At long last, the Canadian Federal Government and the European Commission announced in October that a political agreement has been reached regarding the much anticipated
A recent lawsuit filed by Myriad Genetics involving the alleged infringement of their controversial breast cancer screening tool has included the prestigious Toronto SickKids hospital